Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Embolization, Therapeutic | 28 | 2022 | 238 | 4.520 |
Why?
|
Intracranial Aneurysm | 22 | 2021 | 158 | 4.310 |
Why?
|
Thrombectomy | 13 | 2023 | 158 | 3.920 |
Why?
|
Angiography, Digital Subtraction | 17 | 2024 | 92 | 3.640 |
Why?
|
Stents | 23 | 2022 | 377 | 3.640 |
Why?
|
Cerebral Angiography | 25 | 2019 | 196 | 3.540 |
Why?
|
Endovascular Procedures | 22 | 2021 | 218 | 3.430 |
Why?
|
Intracranial Arteriovenous Malformations | 14 | 2022 | 104 | 3.400 |
Why?
|
Stroke | 23 | 2023 | 965 | 3.170 |
Why?
|
Cerebrovascular Disorders | 10 | 2019 | 143 | 2.600 |
Why?
|
Brain Ischemia | 10 | 2023 | 398 | 2.350 |
Why?
|
Magnetic Resonance Angiography | 17 | 2024 | 262 | 2.050 |
Why?
|
Cerebrovascular Circulation | 10 | 2017 | 212 | 1.820 |
Why?
|
Neuroimaging | 6 | 2019 | 113 | 1.770 |
Why?
|
Magnetic Resonance Imaging | 18 | 2024 | 3362 | 1.640 |
Why?
|
Arteriovenous Fistula | 8 | 2016 | 52 | 1.640 |
Why?
|
Imaging, Three-Dimensional | 11 | 2019 | 579 | 1.620 |
Why?
|
Intracranial Arteriosclerosis | 6 | 2019 | 49 | 1.590 |
Why?
|
Computed Tomography Angiography | 4 | 2018 | 131 | 1.240 |
Why?
|
Surgery, Computer-Assisted | 4 | 2018 | 99 | 1.140 |
Why?
|
Reperfusion | 4 | 2020 | 31 | 1.080 |
Why?
|
Polyvinyls | 5 | 2013 | 17 | 1.080 |
Why?
|
Carotid Artery Diseases | 4 | 2019 | 97 | 1.080 |
Why?
|
Retrospective Studies | 34 | 2023 | 8489 | 1.060 |
Why?
|
Infarction, Middle Cerebral Artery | 3 | 2020 | 35 | 1.060 |
Why?
|
Humans | 128 | 2024 | 86643 | 1.050 |
Why?
|
Treatment Outcome | 38 | 2023 | 7993 | 1.050 |
Why?
|
Middle Aged | 50 | 2021 | 25028 | 1.000 |
Why?
|
Male | 72 | 2022 | 40965 | 0.980 |
Why?
|
Tomography, X-Ray Computed | 14 | 2024 | 2601 | 0.980 |
Why?
|
Vasculitis | 1 | 2024 | 39 | 0.970 |
Why?
|
Aged | 39 | 2024 | 18415 | 0.960 |
Why?
|
Female | 70 | 2021 | 44532 | 0.920 |
Why?
|
Blood Vessel Prosthesis | 7 | 2021 | 228 | 0.900 |
Why?
|
Vasospasm, Intracranial | 3 | 2011 | 36 | 0.880 |
Why?
|
Aneurysm, Ruptured | 8 | 2021 | 51 | 0.870 |
Why?
|
Catheterization | 3 | 2019 | 232 | 0.840 |
Why?
|
Arteriovenous Malformations | 2 | 2013 | 41 | 0.820 |
Why?
|
Hemodynamics | 6 | 2023 | 710 | 0.810 |
Why?
|
After-Hours Care | 1 | 2021 | 8 | 0.790 |
Why?
|
Atherosclerosis | 1 | 2024 | 244 | 0.780 |
Why?
|
Neurosurgical Procedures | 7 | 2021 | 213 | 0.770 |
Why?
|
Time-to-Treatment | 2 | 2021 | 98 | 0.750 |
Why?
|
Cerebral Arteries | 6 | 2017 | 74 | 0.730 |
Why?
|
Intracranial Hemorrhages | 2 | 2018 | 120 | 0.730 |
Why?
|
Radiography, Interventional | 3 | 2010 | 150 | 0.730 |
Why?
|
Vertebral Artery | 3 | 2016 | 23 | 0.700 |
Why?
|
Adult | 40 | 2021 | 25648 | 0.670 |
Why?
|
Neutrophils | 1 | 2020 | 307 | 0.670 |
Why?
|
Platelet Aggregation Inhibitors | 5 | 2021 | 134 | 0.660 |
Why?
|
Lymphocytes | 1 | 2020 | 464 | 0.650 |
Why?
|
Polymers | 2 | 2021 | 202 | 0.640 |
Why?
|
Catheters | 1 | 2018 | 74 | 0.630 |
Why?
|
Carotid Stenosis | 4 | 2022 | 112 | 0.610 |
Why?
|
Gadolinium | 2 | 2016 | 103 | 0.590 |
Why?
|
Carotid Artery, Internal | 3 | 2016 | 69 | 0.590 |
Why?
|
Sensitivity and Specificity | 12 | 2019 | 1991 | 0.580 |
Why?
|
Carotid Artery, Internal, Dissection | 3 | 2014 | 18 | 0.580 |
Why?
|
Subarachnoid Hemorrhage | 4 | 2020 | 137 | 0.570 |
Why?
|
Spinal Cord | 3 | 2014 | 249 | 0.560 |
Why?
|
Pseudotumor Cerebri | 1 | 2016 | 16 | 0.560 |
Why?
|
Plaque, Atherosclerotic | 1 | 2016 | 54 | 0.560 |
Why?
|
Aneurysm, False | 1 | 2016 | 54 | 0.550 |
Why?
|
Radiation Exposure | 1 | 2016 | 24 | 0.550 |
Why?
|
Head and Neck Neoplasms | 4 | 2011 | 1052 | 0.550 |
Why?
|
Nervous System Diseases | 2 | 2020 | 151 | 0.550 |
Why?
|
Tinnitus | 1 | 2016 | 21 | 0.550 |
Why?
|
Radiation Dosage | 2 | 2016 | 227 | 0.550 |
Why?
|
Four-Dimensional Computed Tomography | 1 | 2015 | 18 | 0.550 |
Why?
|
Perfusion Imaging | 2 | 2018 | 50 | 0.540 |
Why?
|
Aged, 80 and over | 14 | 2021 | 6509 | 0.530 |
Why?
|
Burnout, Professional | 3 | 2022 | 94 | 0.510 |
Why?
|
Cerebral Revascularization | 2 | 2014 | 26 | 0.510 |
Why?
|
Cone-Beam Computed Tomography | 2 | 2017 | 64 | 0.500 |
Why?
|
Brain | 7 | 2022 | 2216 | 0.500 |
Why?
|
Reproducibility of Results | 12 | 2019 | 2705 | 0.490 |
Why?
|
Vascular Surgical Procedures | 3 | 2009 | 148 | 0.460 |
Why?
|
Cranial Sinuses | 3 | 2021 | 15 | 0.460 |
Why?
|
Physicians | 5 | 2022 | 673 | 0.450 |
Why?
|
Vertebral Artery Dissection | 2 | 2014 | 11 | 0.450 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2013 | 47 | 0.450 |
Why?
|
Image Enhancement | 5 | 2019 | 563 | 0.420 |
Why?
|
Contrast Media | 8 | 2017 | 1078 | 0.410 |
Why?
|
Carotid Body Tumor | 1 | 2011 | 3 | 0.400 |
Why?
|
Endarterectomy, Carotid | 2 | 2022 | 73 | 0.400 |
Why?
|
Risk Factors | 10 | 2022 | 5417 | 0.400 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2011 | 13 | 0.400 |
Why?
|
Fibrinolytic Agents | 5 | 2018 | 202 | 0.390 |
Why?
|
Cocaine-Related Disorders | 1 | 2011 | 34 | 0.390 |
Why?
|
Hydroxyapatites | 1 | 2010 | 7 | 0.380 |
Why?
|
Molar | 1 | 2010 | 21 | 0.370 |
Why?
|
Blood Flow Velocity | 8 | 2023 | 197 | 0.370 |
Why?
|
Oral Surgical Procedures | 1 | 2010 | 19 | 0.370 |
Why?
|
Hemostasis, Surgical | 1 | 2010 | 26 | 0.370 |
Why?
|
Hemorrhage | 2 | 2014 | 268 | 0.370 |
Why?
|
Carotid Artery Injuries | 1 | 2010 | 22 | 0.370 |
Why?
|
Practice Guidelines as Topic | 5 | 2021 | 1036 | 0.360 |
Why?
|
Young Adult | 10 | 2021 | 5976 | 0.360 |
Why?
|
Algorithms | 4 | 2023 | 1830 | 0.350 |
Why?
|
Diagnosis, Differential | 7 | 2015 | 1565 | 0.350 |
Why?
|
Central Nervous System Vascular Malformations | 4 | 2018 | 32 | 0.350 |
Why?
|
Follow-Up Studies | 6 | 2020 | 3640 | 0.350 |
Why?
|
Job Satisfaction | 2 | 2020 | 73 | 0.340 |
Why?
|
Intracranial Thrombosis | 2 | 2018 | 27 | 0.340 |
Why?
|
Mandible | 1 | 2010 | 119 | 0.340 |
Why?
|
Collateral Circulation | 2 | 2020 | 35 | 0.330 |
Why?
|
Blood Vessel Prosthesis Implantation | 2 | 2021 | 208 | 0.330 |
Why?
|
Radiosurgery | 3 | 2022 | 272 | 0.330 |
Why?
|
Research Report | 2 | 2021 | 44 | 0.320 |
Why?
|
Angioplasty | 3 | 2021 | 70 | 0.320 |
Why?
|
Adolescent | 13 | 2021 | 8981 | 0.320 |
Why?
|
Dimethyl Sulfoxide | 3 | 2013 | 38 | 0.310 |
Why?
|
Eye Diseases | 2 | 2005 | 53 | 0.310 |
Why?
|
Postoperative Complications | 6 | 2020 | 2207 | 0.310 |
Why?
|
Surgical Flaps | 1 | 2010 | 241 | 0.310 |
Why?
|
Diagnostic Imaging | 3 | 2009 | 469 | 0.300 |
Why?
|
Hand | 5 | 1991 | 130 | 0.300 |
Why?
|
Prospective Studies | 7 | 2023 | 4213 | 0.300 |
Why?
|
Single-Blind Method | 3 | 2018 | 153 | 0.300 |
Why?
|
Prevalence | 4 | 2021 | 1239 | 0.290 |
Why?
|
Neurosurgery | 3 | 2020 | 84 | 0.290 |
Why?
|
Cerebral Veins | 3 | 2016 | 30 | 0.290 |
Why?
|
Pandemics | 3 | 2021 | 740 | 0.280 |
Why?
|
Rotavirus | 3 | 1991 | 11 | 0.280 |
Why?
|
Risk Assessment | 6 | 2022 | 2261 | 0.280 |
Why?
|
Societies, Medical | 3 | 2021 | 572 | 0.280 |
Why?
|
Pilot Projects | 5 | 2017 | 839 | 0.270 |
Why?
|
Vertebrobasilar Insufficiency | 2 | 2017 | 16 | 0.270 |
Why?
|
Lacrimal Apparatus Diseases | 1 | 2005 | 1 | 0.260 |
Why?
|
Carotid-Cavernous Sinus Fistula | 3 | 2009 | 4 | 0.260 |
Why?
|
Orbital Neoplasms | 1 | 2005 | 17 | 0.260 |
Why?
|
Lacrimal Apparatus | 1 | 2005 | 11 | 0.260 |
Why?
|
Eye Neoplasms | 1 | 2005 | 27 | 0.260 |
Why?
|
Surveys and Questionnaires | 4 | 2022 | 2501 | 0.260 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 316 | 0.260 |
Why?
|
Coronavirus Infections | 2 | 2020 | 301 | 0.260 |
Why?
|
Diffusion Magnetic Resonance Imaging | 3 | 2020 | 294 | 0.250 |
Why?
|
Eye | 1 | 2005 | 111 | 0.250 |
Why?
|
Hemangioma, Cavernous | 1 | 2005 | 69 | 0.250 |
Why?
|
Radiology, Interventional | 3 | 2009 | 68 | 0.250 |
Why?
|
Multimorbidity | 1 | 2024 | 5 | 0.240 |
Why?
|
Fatal Outcome | 2 | 2016 | 293 | 0.240 |
Why?
|
National Health Programs | 1 | 2024 | 20 | 0.240 |
Why?
|
Medicare | 2 | 2018 | 410 | 0.240 |
Why?
|
Image Interpretation, Computer-Assisted | 3 | 2019 | 663 | 0.230 |
Why?
|
Treatment Failure | 2 | 2021 | 285 | 0.230 |
Why?
|
Phantoms, Imaging | 4 | 2019 | 429 | 0.230 |
Why?
|
Artifacts | 4 | 2013 | 244 | 0.220 |
Why?
|
Polycystic Kidney, Autosomal Dominant | 2 | 2015 | 136 | 0.220 |
Why?
|
Elective Surgical Procedures | 2 | 2021 | 116 | 0.220 |
Why?
|
Time Factors | 7 | 2021 | 5210 | 0.210 |
Why?
|
Delivery of Health Care | 3 | 2024 | 426 | 0.210 |
Why?
|
Carotid Arteries | 2 | 2021 | 127 | 0.210 |
Why?
|
Cohort Studies | 9 | 2023 | 2767 | 0.200 |
Why?
|
Child | 10 | 2021 | 6927 | 0.200 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2021 | 11 | 0.200 |
Why?
|
Regional Blood Flow | 2 | 2019 | 197 | 0.200 |
Why?
|
Embolic Protection Devices | 1 | 2021 | 9 | 0.200 |
Why?
|
Embolism | 1 | 2021 | 31 | 0.200 |
Why?
|
Neurosurgeons | 1 | 2021 | 25 | 0.200 |
Why?
|
Hospitals, Community | 1 | 2021 | 32 | 0.200 |
Why?
|
Hand Disinfection | 2 | 1991 | 17 | 0.190 |
Why?
|
Hydralazine | 1 | 2020 | 20 | 0.190 |
Why?
|
North America | 1 | 2021 | 180 | 0.190 |
Why?
|
Spinal Cord Ischemia | 1 | 2020 | 8 | 0.190 |
Why?
|
United States | 11 | 2022 | 6672 | 0.190 |
Why?
|
Patient Readmission | 2 | 2022 | 329 | 0.190 |
Why?
|
Acute Disease | 2 | 2014 | 826 | 0.190 |
Why?
|
Neck | 2 | 2013 | 100 | 0.190 |
Why?
|
Observer Variation | 4 | 2016 | 602 | 0.190 |
Why?
|
Thoracic Vertebrae | 1 | 2020 | 49 | 0.190 |
Why?
|
Emergencies | 1 | 2021 | 113 | 0.190 |
Why?
|
Academic Medical Centers | 2 | 2021 | 379 | 0.190 |
Why?
|
Thrombolytic Therapy | 2 | 2021 | 220 | 0.180 |
Why?
|
Basilar Artery | 1 | 2020 | 41 | 0.180 |
Why?
|
Norepinephrine | 1 | 2020 | 167 | 0.180 |
Why?
|
Conservative Treatment | 1 | 2020 | 20 | 0.180 |
Why?
|
Permeability | 2 | 2017 | 137 | 0.180 |
Why?
|
Hydrogels | 1 | 2020 | 82 | 0.180 |
Why?
|
Lumbar Vertebrae | 1 | 2020 | 148 | 0.180 |
Why?
|
Intracranial Embolism | 1 | 2019 | 29 | 0.180 |
Why?
|
Social Media | 1 | 2021 | 79 | 0.170 |
Why?
|
Ki-67 Antigen | 1 | 2019 | 64 | 0.170 |
Why?
|
Health Expenditures | 2 | 2018 | 86 | 0.170 |
Why?
|
Minimally Invasive Surgical Procedures | 2 | 2013 | 237 | 0.170 |
Why?
|
Computer Graphics | 1 | 2019 | 100 | 0.170 |
Why?
|
Coated Materials, Biocompatible | 2 | 2011 | 30 | 0.170 |
Why?
|
Embolectomy | 2 | 2015 | 5 | 0.170 |
Why?
|
Physician's Role | 1 | 2020 | 179 | 0.160 |
Why?
|
Microsurgery | 1 | 2019 | 84 | 0.160 |
Why?
|
Preoperative Care | 2 | 2012 | 397 | 0.160 |
Why?
|
Vascular Closure Devices | 1 | 2018 | 3 | 0.160 |
Why?
|
Angiography | 3 | 2020 | 208 | 0.160 |
Why?
|
Chicago | 2 | 2021 | 1379 | 0.160 |
Why?
|
Multimodal Imaging | 2 | 2017 | 110 | 0.160 |
Why?
|
Spinal Diseases | 2 | 2020 | 44 | 0.160 |
Why?
|
Cross-Sectional Studies | 3 | 2024 | 1621 | 0.160 |
Why?
|
Drug Therapy, Combination | 1 | 2020 | 894 | 0.160 |
Why?
|
Neuroendoscopy | 1 | 2018 | 14 | 0.160 |
Why?
|
Intracranial Hypertension | 2 | 2016 | 48 | 0.160 |
Why?
|
Health Personnel | 1 | 2020 | 202 | 0.160 |
Why?
|
Disease Management | 2 | 2017 | 327 | 0.160 |
Why?
|
Foreign Bodies | 1 | 2018 | 63 | 0.160 |
Why?
|
Escherichia coli | 2 | 1991 | 597 | 0.150 |
Why?
|
Neurovascular Coupling | 1 | 2017 | 2 | 0.150 |
Why?
|
Registries | 2 | 2019 | 702 | 0.150 |
Why?
|
Hospitals, Urban | 1 | 2017 | 54 | 0.150 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2019 | 1204 | 0.150 |
Why?
|
Thrombosis | 1 | 2020 | 296 | 0.150 |
Why?
|
Pia Mater | 1 | 2016 | 5 | 0.150 |
Why?
|
Glioblastoma | 1 | 2019 | 255 | 0.150 |
Why?
|
Betacoronavirus | 1 | 2020 | 258 | 0.150 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2019 | 381 | 0.140 |
Why?
|
Superior Sagittal Sinus | 1 | 2016 | 2 | 0.140 |
Why?
|
Patient Selection | 3 | 2021 | 685 | 0.140 |
Why?
|
Cerebral Infarction | 1 | 2016 | 71 | 0.140 |
Why?
|
Arteriosclerosis | 1 | 2016 | 113 | 0.140 |
Why?
|
Veins | 1 | 2016 | 94 | 0.140 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2016 | 66 | 0.140 |
Why?
|
Coronary Circulation | 1 | 2016 | 130 | 0.130 |
Why?
|
Combined Modality Therapy | 3 | 2019 | 1686 | 0.130 |
Why?
|
Attitude of Health Personnel | 1 | 2020 | 636 | 0.130 |
Why?
|
Brain Neoplasms | 2 | 2019 | 763 | 0.130 |
Why?
|
Case-Control Studies | 1 | 2019 | 1805 | 0.130 |
Why?
|
Platelet Function Tests | 1 | 2014 | 11 | 0.130 |
Why?
|
Arterial Occlusive Diseases | 1 | 2015 | 107 | 0.120 |
Why?
|
Capillary Permeability | 1 | 2015 | 130 | 0.120 |
Why?
|
Thromboembolism | 2 | 2014 | 119 | 0.120 |
Why?
|
Anticoagulants | 2 | 2014 | 408 | 0.120 |
Why?
|
Radiography | 2 | 2013 | 813 | 0.120 |
Why?
|
Biomarkers | 1 | 2020 | 1718 | 0.120 |
Why?
|
Hoarseness | 1 | 2013 | 11 | 0.120 |
Why?
|
Models, Theoretical | 1 | 2016 | 482 | 0.120 |
Why?
|
Vocal Cord Paralysis | 1 | 2013 | 26 | 0.120 |
Why?
|
Moyamoya Disease | 1 | 2013 | 14 | 0.120 |
Why?
|
Syndrome | 2 | 2011 | 446 | 0.120 |
Why?
|
Platinum | 2 | 2020 | 63 | 0.120 |
Why?
|
Tissue Plasminogen Activator | 2 | 2015 | 162 | 0.110 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 378 | 0.110 |
Why?
|
Fistula | 1 | 2013 | 42 | 0.110 |
Why?
|
Vertebroplasty | 1 | 2013 | 8 | 0.110 |
Why?
|
Radiographic Image Enhancement | 1 | 2015 | 462 | 0.110 |
Why?
|
Needles | 1 | 2013 | 35 | 0.110 |
Why?
|
Ventriculostomy | 1 | 2013 | 26 | 0.110 |
Why?
|
Competency-Based Education | 1 | 2013 | 35 | 0.110 |
Why?
|
Illinois | 1 | 2014 | 462 | 0.110 |
Why?
|
Aortic Coarctation | 1 | 2012 | 35 | 0.110 |
Why?
|
Astrocytoma | 1 | 2012 | 82 | 0.100 |
Why?
|
Paramyxoviridae Infections | 1 | 1991 | 5 | 0.100 |
Why?
|
Common Cold | 1 | 1991 | 13 | 0.100 |
Why?
|
Antihypertensive Agents | 1 | 2016 | 521 | 0.100 |
Why?
|
Disinfection | 1 | 1991 | 14 | 0.100 |
Why?
|
Rotavirus Infections | 1 | 1991 | 12 | 0.100 |
Why?
|
Length of Stay | 3 | 2015 | 702 | 0.100 |
Why?
|
Hemostasis | 1 | 2011 | 21 | 0.100 |
Why?
|
Gastroenteritis | 1 | 1991 | 27 | 0.100 |
Why?
|
Injections | 1 | 2011 | 109 | 0.100 |
Why?
|
Aging | 1 | 2016 | 691 | 0.100 |
Why?
|
Postpartum Period | 1 | 2011 | 135 | 0.100 |
Why?
|
Iatrogenic Disease | 1 | 2011 | 69 | 0.100 |
Why?
|
Early Diagnosis | 1 | 2011 | 131 | 0.100 |
Why?
|
Respiratory Tract Infections | 1 | 1991 | 105 | 0.100 |
Why?
|
Predictive Value of Tests | 2 | 2016 | 1673 | 0.100 |
Why?
|
Injections, Intralesional | 1 | 2010 | 22 | 0.090 |
Why?
|
Headache | 1 | 2011 | 73 | 0.090 |
Why?
|
Alveolar Bone Loss | 1 | 2010 | 20 | 0.090 |
Why?
|
Child, Preschool | 4 | 2021 | 3612 | 0.090 |
Why?
|
Disease Outbreaks | 1 | 1991 | 154 | 0.090 |
Why?
|
Databases, Factual | 3 | 2021 | 814 | 0.090 |
Why?
|
Recurrence | 3 | 2020 | 1139 | 0.090 |
Why?
|
Survival Rate | 1 | 2014 | 1863 | 0.090 |
Why?
|
Anti-Infective Agents, Local | 1 | 1989 | 23 | 0.090 |
Why?
|
Oculomotor Nerve Diseases | 1 | 2009 | 7 | 0.090 |
Why?
|
Hospitalization | 1 | 2015 | 849 | 0.090 |
Why?
|
Neoplasms, Vascular Tissue | 1 | 2009 | 3 | 0.090 |
Why?
|
Hemostatics | 1 | 2009 | 56 | 0.090 |
Why?
|
Iohexol | 1 | 2009 | 26 | 0.090 |
Why?
|
Cerebrovascular Trauma | 1 | 2009 | 3 | 0.090 |
Why?
|
Ambulatory Care | 1 | 2010 | 181 | 0.090 |
Why?
|
Neuroradiography | 1 | 2008 | 3 | 0.080 |
Why?
|
Statistics as Topic | 1 | 2009 | 238 | 0.080 |
Why?
|
Infant | 4 | 2016 | 3046 | 0.080 |
Why?
|
Incidence | 3 | 2020 | 1577 | 0.080 |
Why?
|
Equipment Contamination | 1 | 1988 | 22 | 0.080 |
Why?
|
Hyperthermia, Induced | 1 | 2009 | 73 | 0.080 |
Why?
|
Critical Illness | 1 | 2011 | 294 | 0.080 |
Why?
|
Disease Progression | 1 | 2013 | 1531 | 0.080 |
Why?
|
Hospital Mortality | 3 | 2021 | 349 | 0.080 |
Why?
|
Mass Screening | 1 | 2013 | 618 | 0.080 |
Why?
|
Anesthesia | 1 | 2010 | 164 | 0.080 |
Why?
|
Dogs | 2 | 2020 | 685 | 0.080 |
Why?
|
Head | 1 | 2008 | 132 | 0.080 |
Why?
|
Anesthesiology | 1 | 2010 | 157 | 0.080 |
Why?
|
Severity of Illness Index | 1 | 2013 | 1801 | 0.080 |
Why?
|
Cerebral Hemorrhage | 1 | 2010 | 325 | 0.080 |
Why?
|
Emergency Service, Hospital | 1 | 2010 | 484 | 0.070 |
Why?
|
Brain Injuries | 1 | 2009 | 161 | 0.070 |
Why?
|
Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2006 | 31 | 0.070 |
Why?
|
Inpatients | 2 | 2022 | 297 | 0.070 |
Why?
|
Aneurysm | 2 | 2017 | 58 | 0.060 |
Why?
|
ROC Curve | 2 | 2019 | 752 | 0.060 |
Why?
|
Neurologic Examination | 2 | 2016 | 118 | 0.060 |
Why?
|
Health Care Costs | 1 | 2006 | 238 | 0.060 |
Why?
|
Australia | 1 | 2024 | 99 | 0.060 |
Why?
|
Logistic Models | 2 | 2019 | 1186 | 0.060 |
Why?
|
Infant, Newborn | 2 | 2021 | 2379 | 0.060 |
Why?
|
Spine | 2 | 2013 | 102 | 0.050 |
Why?
|
Aorta, Thoracic | 1 | 2023 | 165 | 0.050 |
Why?
|
Equipment Design | 2 | 2018 | 406 | 0.050 |
Why?
|
Feasibility Studies | 2 | 2015 | 751 | 0.050 |
Why?
|
Fatigue | 1 | 2022 | 174 | 0.050 |
Why?
|
Accidents, Traffic | 1 | 2022 | 94 | 0.050 |
Why?
|
Medical Errors | 1 | 2022 | 115 | 0.050 |
Why?
|
Patient Acceptance of Health Care | 1 | 2024 | 238 | 0.050 |
Why?
|
Sleep Deprivation | 1 | 2022 | 137 | 0.050 |
Why?
|
Infarction | 1 | 2020 | 26 | 0.050 |
Why?
|
Computer Simulation | 2 | 2017 | 1078 | 0.050 |
Why?
|
Vasoconstrictor Agents | 1 | 2020 | 53 | 0.050 |
Why?
|
Chronic Disease | 1 | 2024 | 971 | 0.050 |
Why?
|
Retreatment | 1 | 2020 | 107 | 0.050 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 73 | 0.050 |
Why?
|
Vasodilator Agents | 1 | 2020 | 152 | 0.040 |
Why?
|
Age Factors | 2 | 2016 | 1851 | 0.040 |
Why?
|
Patient Admission | 1 | 2020 | 112 | 0.040 |
Why?
|
Personal Satisfaction | 1 | 2019 | 62 | 0.040 |
Why?
|
Calcinosis | 1 | 2019 | 224 | 0.040 |
Why?
|
Aortic Valve Stenosis | 1 | 2019 | 131 | 0.040 |
Why?
|
Decision Making | 1 | 2023 | 642 | 0.040 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2019 | 166 | 0.040 |
Why?
|
Aortic Valve | 1 | 2019 | 222 | 0.040 |
Why?
|
Tumor Burden | 1 | 2019 | 289 | 0.040 |
Why?
|
Urban Health Services | 1 | 2017 | 45 | 0.040 |
Why?
|
Cardiac-Gated Imaging Techniques | 1 | 2017 | 19 | 0.040 |
Why?
|
Vascular Diseases | 1 | 2018 | 121 | 0.040 |
Why?
|
Fee-for-Service Plans | 1 | 2016 | 30 | 0.040 |
Why?
|
Sample Size | 1 | 2017 | 130 | 0.040 |
Why?
|
Middle Cerebral Artery | 1 | 2016 | 21 | 0.040 |
Why?
|
Mechanical Thrombolysis | 1 | 2016 | 15 | 0.030 |
Why?
|
Sinus Thrombosis, Intracranial | 1 | 2016 | 13 | 0.030 |
Why?
|
Morbidity | 1 | 2016 | 148 | 0.030 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2017 | 201 | 0.030 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2016 | 47 | 0.030 |
Why?
|
Patient Safety | 1 | 2018 | 212 | 0.030 |
Why?
|
Surgical Instruments | 1 | 2015 | 57 | 0.030 |
Why?
|
Dominance, Cerebral | 1 | 2015 | 66 | 0.030 |
Why?
|
Constriction, Pathologic | 1 | 2016 | 213 | 0.030 |
Why?
|
Microcirculation | 1 | 2015 | 106 | 0.030 |
Why?
|
Hospital Costs | 1 | 2015 | 105 | 0.030 |
Why?
|
Kinetics | 1 | 2017 | 1513 | 0.030 |
Why?
|
Multivariate Analysis | 1 | 2017 | 999 | 0.030 |
Why?
|
Shear Strength | 1 | 2013 | 19 | 0.030 |
Why?
|
Motivation | 1 | 2016 | 287 | 0.030 |
Why?
|
Longitudinal Studies | 1 | 2017 | 1019 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2021 | 827 | 0.030 |
Why?
|
Models, Cardiovascular | 1 | 2013 | 98 | 0.030 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 2014 | 81 | 0.030 |
Why?
|
Models, Statistical | 1 | 2017 | 574 | 0.030 |
Why?
|
Drug Resistance | 1 | 2014 | 256 | 0.030 |
Why?
|
Muscle Weakness | 1 | 2013 | 61 | 0.030 |
Why?
|
Administration, Oral | 1 | 2014 | 684 | 0.030 |
Why?
|
Animals | 4 | 2020 | 26582 | 0.030 |
Why?
|
Causality | 1 | 2013 | 81 | 0.030 |
Why?
|
Fluoroscopy | 1 | 2013 | 119 | 0.030 |
Why?
|
Stress, Mechanical | 1 | 2013 | 248 | 0.030 |
Why?
|
Software | 1 | 2017 | 654 | 0.030 |
Why?
|
Cerebrospinal Fluid Shunts | 1 | 2013 | 48 | 0.030 |
Why?
|
Temporal Lobe | 1 | 2013 | 172 | 0.030 |
Why?
|
Sex Factors | 1 | 2016 | 1054 | 0.030 |
Why?
|
Magnetic Fields | 1 | 2012 | 11 | 0.030 |
Why?
|
Gadolinium DTPA | 1 | 2013 | 261 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2016 | 865 | 0.030 |
Why?
|
Parainfluenza Virus 3, Human | 1 | 1991 | 2 | 0.030 |
Why?
|
Disinfectants | 1 | 1991 | 8 | 0.030 |
Why?
|
Recovery of Function | 1 | 2013 | 272 | 0.030 |
Why?
|
Rhinovirus | 1 | 1991 | 25 | 0.030 |
Why?
|
Needs Assessment | 1 | 2013 | 154 | 0.030 |
Why?
|
Fellowships and Scholarships | 1 | 2013 | 108 | 0.030 |
Why?
|
Air Microbiology | 1 | 1991 | 5 | 0.030 |
Why?
|
User-Computer Interface | 1 | 2013 | 185 | 0.030 |
Why?
|
Water Microbiology | 1 | 1991 | 13 | 0.030 |
Why?
|
Michigan | 1 | 2010 | 52 | 0.020 |
Why?
|
Pain | 1 | 2013 | 391 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2010 | 229 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2013 | 429 | 0.020 |
Why?
|
Soaps | 1 | 1989 | 2 | 0.020 |
Why?
|
Fresh Water | 1 | 1989 | 19 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2016 | 2232 | 0.020 |
Why?
|
Seasons | 1 | 1991 | 223 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2010 | 429 | 0.020 |
Why?
|
Global Health | 1 | 1991 | 193 | 0.020 |
Why?
|
Medically Underserved Area | 1 | 2009 | 25 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 1169 | 0.020 |
Why?
|
Craniotomy | 1 | 2010 | 88 | 0.020 |
Why?
|
Carotid Artery, External | 1 | 2009 | 8 | 0.020 |
Why?
|
Deep Brain Stimulation | 1 | 2010 | 54 | 0.020 |
Why?
|
Reference Values | 1 | 2010 | 674 | 0.020 |
Why?
|
Injections, Intra-Arterial | 1 | 2009 | 33 | 0.020 |
Why?
|
Accidents, Occupational | 1 | 2009 | 8 | 0.020 |
Why?
|
Cavernous Sinus | 1 | 2009 | 15 | 0.020 |
Why?
|
Spinal Fusion | 1 | 2010 | 85 | 0.020 |
Why?
|
Comorbidity | 1 | 2013 | 943 | 0.020 |
Why?
|
Emergency Medicine | 1 | 2010 | 123 | 0.020 |
Why?
|
Steel | 1 | 1988 | 1 | 0.020 |
Why?
|
Conjunctivitis, Acute Hemorrhagic | 1 | 1988 | 1 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2010 | 916 | 0.020 |
Why?
|
Enterovirus | 1 | 1988 | 34 | 0.020 |
Why?
|
Odds Ratio | 1 | 2010 | 678 | 0.020 |
Why?
|
Drug-Related Side Effects and Adverse Reactions | 1 | 2010 | 199 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2010 | 859 | 0.020 |
Why?
|
Feces | 1 | 1989 | 319 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2014 | 1376 | 0.020 |
Why?
|
Clinical Competence | 1 | 2013 | 751 | 0.020 |
Why?
|
Radiology | 1 | 2009 | 194 | 0.020 |
Why?
|
Cell Line | 2 | 1988 | 2468 | 0.020 |
Why?
|
Survival Analysis | 1 | 2010 | 1538 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2010 | 1961 | 0.020 |
Why?
|
Skin | 1 | 1988 | 554 | 0.020 |
Why?
|
Internship and Residency | 1 | 2013 | 1004 | 0.010 |
Why?
|
Prognosis | 1 | 2010 | 3679 | 0.010 |
Why?
|
Humidity | 1 | 1988 | 89 | 0.010 |
Why?
|
Temperature | 1 | 1988 | 396 | 0.000 |
Why?
|
Models, Biological | 1 | 1988 | 1749 | 0.000 |
Why?
|